Beijing Chunlizhengda Medical Instruments Co., Ltd. Class H (HK:1858)
:1858
1858 Stock Chart & Stats
HK$15.39
-HK$0.21(-2.63%)
At close: 4:00 PM EST
HK$15.39
-HK$0.21(-2.63%)
Day’s Range― - ―
52-Week RangeHK$8.59 - HK$20.82
Previous CloseN/A
Volume218.00K
Average Volume (3M)1.20M
Market Cap
HK$8.03B
Enterprise ValueHK$6.43B
Total Cash (Recent Filing)HK$2.22B
Total Debt (Recent Filing)HK$3.78M
Price to Earnings (P/E)17.5
Beta1.15
Next Earnings
Apr 30, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield1.88%
Share Statistics
EPS (TTM)0.23
Shares Outstanding95,140,500
10 Day Avg. Volume978,626
30 Day Avg. Volume1,198,522
Financial Highlights & Ratios
PEG Ratio0.18
Price to Book (P/B)1.71
Price to Sales (P/S)5.06
P/FCF Ratio14.53
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)0.81
Revenue Forecast (FY)HK$1.43B
Bulls Say, Bears Say
Bulls Say
High Margins & ProfitabilityThe company’s persistently high gross and net margins create durable operating leverage and pricing power in its medical-device niche. Strong margins support reinvestment in R&D, sustain cash returns to stakeholders, and provide resilience against revenue volatility over the medium term.
Exceptionally Conservative Balance SheetNear-zero leverage and a large equity base materially reduce financial distress risk and preserve optionality. This conservatism supports capital allocation flexibility for capex, M&A, or downturns, enabling the company to navigate cyclical medical-device demand without forced deleveraging.
Strong Recent Free Cash FlowFree cash flow that approaches reported earnings in recent years indicates the business can convert profits into cash. The 2025 improvement strengthens liquidity and funds reinvestment or distributions, enhancing the company’s ability to finance growth without additional leverage.
Bears Say
Inconsistent Revenue GrowthConsecutive annual revenue declines point to demand softness or loss of momentum in the company’s markets. Persistent top-line weakness undermines long-term margin expansion prospects and stresses the business model’s ability to scale profitably, constraining sustainable earnings growth.
Volatile Operating Cash FlowsIntermittent negative operating cash flow despite profitability signals working-capital or earnings-quality issues. This volatility can complicate capital budgeting and dividend consistency, increasing execution risk and making financial planning less predictable over the medium term.
ROE Not Consistently ImprovingModerating and non-trending ROE suggests limited gains in asset efficiency or margin expansion even with low leverage. Without improving return on invested capital, shareholder returns may be constrained and the company could struggle to translate scale into higher profitability.
Beijing Chunlizhengda Medical Instruments Co., Ltd. Class H News
1858 FAQ
What was Beijing Chunlizhengda Medical Instruments Co., Ltd. Class H’s price range in the past 12 months?
Beijing Chunlizhengda Medical Instruments Co., Ltd. Class H lowest stock price was HK$8.59 and its highest was HK$20.82 in the past 12 months.
What is Beijing Chunlizhengda Medical Instruments Co., Ltd. Class H’s market cap?
Beijing Chunlizhengda Medical Instruments Co., Ltd. Class H’s market cap is HK$8.03B.
When is Beijing Chunlizhengda Medical Instruments Co., Ltd. Class H’s upcoming earnings report date?
Beijing Chunlizhengda Medical Instruments Co., Ltd. Class H’s upcoming earnings report date is Apr 30, 2026 which is in 19 days.
How were Beijing Chunlizhengda Medical Instruments Co., Ltd. Class H’s earnings last quarter?
Beijing Chunlizhengda Medical Instruments Co., Ltd. Class H released its earnings results on Mar 30, 2026. The company reported HK$0.232 earnings per share for the quarter, beating the consensus estimate of N/A by HK$0.232.
Is Beijing Chunlizhengda Medical Instruments Co., Ltd. Class H overvalued?
According to Wall Street analysts Beijing Chunlizhengda Medical Instruments Co., Ltd. Class H’s price is currently Overvalued.
Does Beijing Chunlizhengda Medical Instruments Co., Ltd. Class H pay dividends?
Beijing Chunlizhengda Medical Instruments Co., Ltd. Class H pays a Semiannually dividend of HK$0.23 which represents an annual dividend yield of 1.88%. See more information on Beijing Chunlizhengda Medical Instruments Co., Ltd. Class H dividends here
What is Beijing Chunlizhengda Medical Instruments Co., Ltd. Class H’s EPS estimate?
Beijing Chunlizhengda Medical Instruments Co., Ltd. Class H’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Beijing Chunlizhengda Medical Instruments Co., Ltd. Class H have?
Beijing Chunlizhengda Medical Instruments Co., Ltd. Class H has 95,140,500 shares outstanding.
What happened to Beijing Chunlizhengda Medical Instruments Co., Ltd. Class H’s price movement after its last earnings report?
Beijing Chunlizhengda Medical Instruments Co., Ltd. Class H reported an EPS of HK$0.232 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -1.26%.
Which hedge fund is a major shareholder of Beijing Chunlizhengda Medical Instruments Co., Ltd. Class H?
Currently, no hedge funds are holding shares in HK:1858
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Beijing Chunlizhengda Medical Instruments Co., Ltd. Class H Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
99.89%
12-Months-Change
Fundamentals
Return on Equity
9.39%
Trailing 12-Months
Asset Growth
10.50%
Trailing 12-Months
Company Description
Beijing Chunlizhengda Medical Instruments Co., Ltd. Class H
Beijing Chunlizhengda Medical Instruments Co., Ltd., an orthopedic medical device company, engages in the research and development, production, and sale of surgical implants, instruments, and related products in the People's Republic of China. It offers implantable orthopedic medical devices, which consist of joint prosthesis products and spinal products. The company primarily sells its products through distributors, or on ODM and OEM bases under the Chunli brand, as well as to hospitals directly. It also exports its products to various countries. The company was incorporated in 1998 and is headquartered in Beijing, China.
Beijing Chunlizhengda Medical Instruments Co., Ltd. Class H (1858) Earnings & Revenues
Technical Analysis
Peijia Medical Ltd.
―
Zylox-Tonbridge Medical Technology Co., Ltd. Class H
―
LifeTech Scientific Corporation
―
China Isotope & Radiation Corp.
―
AK Medical Holdings Ltd.
―
Options Prices
Currently, No data available
---